About

Richard J. Lin, MD, is a Professor of Clinical Anesthesiology and Critical Care at the Perelman School of Medicine at the University of Pennsylvania. He serves as an Attending Physician in Pediatric Critical Care Medicine at the Children's Hospital of Philadelphia, where he also holds the position of Clinical Director of the Progressive Care Unit and Medical Director of the Department of Respiratory Care. Dr. Lin is a member of the Institutional Review Board at Children's Hospital of Philadelphia. His educational background includes a BSE in Chemical Engineering from Princeton University, obtained in 1985, and an MD from the University of Pennsylvania School of Medicine, completed in 1993.

Research topics

• Medicine
• Internal medicine
• Psychiatry
• Physical therapy
• Biology
• Genetics
• Gerontology
• Immunology

Selected publications

• Pharmacokinetic Modeling Identifies Optimal Fludarabine Exposure for Improved Outcomes Following Allogeneic Transplantation with Post-Transplant Cyclophosphamide

  Transplantation and Cellular Therapy · 2026-02-01

  article
  PublisherDOI

• Survival of the Oldest-Old: Allogeneic Transplantation Above 75 Years of Age

  Transplantation and Cellular Therapy · 2026-02-01

  article1st authorCorresponding
  PublisherDOI

• Higher Fludarabine Exposure Correlates with Attenuated Systemic Inflammation and Improved Outcomes after CD19 CAR-T for Large B-cell Lymphoma

  Transplantation and Cellular Therapy · 2026-02-01

  article
  PublisherDOI

• Bridging Radiotherapy Improves Systemic Inflammation before CAR T-cell Therapy (CAR-T)

  Transplantation and Cellular Therapy · 2026-02-01

  article
  PublisherDOI

• Effect of Mycophenolate Mofetil Levels on Transplant Outcomes in Patients Treated with Post-Transplant Cyclophosphamide Based GVHD Prophylaxis

  Transplantation and Cellular Therapy · 2026-02-01

  article
  PublisherDOI

• Cartiac: Comparative Cardiovascular Safety of CAR T Products for Non-Hodgkin’s Lymphoma – a Propensity Score–Matched International Multicenter Study

  Transplantation and Cellular Therapy · 2026-02-01

  article
  PublisherDOI

• A Blood Inflammatory Signature Independently Predicts Treatment Failure after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

  Transplantation and Cellular Therapy · 2026-02-01

  article
  PublisherDOI

• Characterization of TPO Receptor Agonists for the Management of Thrombocytopenia after CAR T-cell Therapy

  Transplantation and Cellular Therapy · 2026-02-01

  article
  PublisherDOI

• Utility of Comorbidity Indices for Informing Outcomes after CAR-T Therapy in Large B-cell Lymphoma: A Multi-Center Observational Study

  Transplantation and Cellular Therapy · 2026-02-01

  article
  PublisherDOI

• The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 Alterations

  Transplantation and Cellular Therapy · 2026-04-01

  articleSenior author
  PublisherDOI

Frequent coauthors

• Miguel-Ángel Perales

  218 shared

• Sergio Giralt

  Memorial Sloan Kettering Cancer Center

  184 shared

• Parastoo B. Dahi

  Memorial Sloan Kettering Cancer Center

  180 shared

• Gunjan L. Shah

  Kettering University

  173 shared

• Michael Scordo

  Cornell University

  152 shared

• Roni Shouval

  Memorial Sloan Kettering Cancer Center

  134 shared

• Sean M. Devlin

  Memorial Sloan Kettering Cancer Center

  106 shared

• Gilles Salles

  Cornell University

  94 shared

Labs

• Richard J. Lin LaboratoryPI

Education

• MD, Health Sciences and Technology (HST)

  Harvard Medical School

  2006

• PhD, Molecular Pathology

  University of California San Diego School of Medicine

  2000